The Annexure

News to 9 October 2026 ·

Desk›Healthcare› Bharat Immunologicals & Biologicals Corporation Ltd

Bharat Immunologicals & Biologicals Corporation Ltd

BSE 524663 · NSE BIBCL · ISIN INE994B01014 · Group B · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

Disclosure profile 2 filings in the window

0 median 17.0 p75 · 25 sector max 52 2 2th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Procedural
Clarification1
Other Update1
Procedural sub-total2
Total2

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

2 filings · 0 selected · busiest 2026-09-17 and 2026-09-30

Filing rhythm · the twelve most recent

2026-09-172026-09-30

SelectedProcedural

Filings

2 in the window

  1. 30 September 2026 ·

    Clarification

    Clarification sought from Bharat Immunologicals & Biologicals Corporation Ltd

    The Exchange has sought clarification from Bharat Immunologicals & Biologicals Corporation Ltd on September 30, 2026 with reference to significant movement in price, in order to ensure ....

    Company Update / Clarification

  2. 17 September 2026 ·

    Other Update

    Winding-up

    Pursuant to the Regulation 30 and other applicable Regulation(s) of SEBI LODR, It is informed that the Government of India has approved the closure of Bharat Immunologicals and Biologicals ....

    Company Update / Winding-up View filing →

RSS feed for Bharat Immunologicals & Biologicals Corporation Ltd · the 50 most recent filings